accepted
on 01 Jun 2021
Last Applicant/ Owned by
215 FIRST STREET, SUITE 7
CAMBRIDGE
MA
02142
Serial Number
85643841 filed on 05th Jun 2012
Registration Number
4653265 registered on 09th Dec 2014
Correspondent Address
Paul C. Llewellyn
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"THERAPEUTICS"
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies "THERAPEUTICS" pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acRead More
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
12th Jul 2012
15th Oct 2014
pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
12th Jul 2012
15th Oct 2014
No 85643841
No Service Mark
No 1053686-0002
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 09th Dec 2023 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 01st Jun 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 01st Jun 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 01st Jun 2021 | REGISTERED - SEC. 15 ACKNOWLEDGED |
| 01st Jun 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 01st Jun 2021 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED |
| 16th Nov 2020 | TEAS SECTION 8 RECEIVED |
| 16th Nov 2020 | TEAS SECTION 15 RECEIVED |
| 09th Dec 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 02th Mar 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
